Cyclobenzaprine: Difference between revisions
Matt Pijoan (talk | contribs) m (Protected "Cyclobenzaprine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
Gerald Chi (talk | contribs) m (Changed protection level for "Cyclobenzaprine" ([Edit=Allow only autoconfirmed users] (expires 22:25, 1 August 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 22:25, 1 August 2014 (UTC)))) |
(No difference)
| |
Revision as of 22:25, 1 July 2014
Synonyms / Brand Names: Cyclobenzaprine HCL, Cyclobenz, Flexeril, Flexiban, Proeptatriene, Proheptatriene
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dosing and Administration
For most patients, the recommended dose of Cyclobenzaprine HCI is 5 mg three times
a day. Based on individual patient response,the dose may be increased to either 7.5
mg or 10 mg three times a day. Use of Cyclobenzaprine HCI for periods longer than two
or three weeks is not recommended.
Less frequent dosing should be considered for hepatically impaired or elderly patients.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Cyclobenzaprine
Return to top
Publication Resources
Most Recent Articles on Cyclobenzaprine
Review Articles on Cyclobenzaprine
Articles on Cyclobenzaprine in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Cyclobenzaprine
Return to top
Trial Resources
Ongoing Trials with Cyclobenzaprine at Clinical Trials.gov
Trial Results with Cyclobenzaprine
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Cyclobenzaprine
Cochrane Collaboration on Cyclobenzaprine
Cost Effectiveness of Cyclobenzaprine
Return to top
Media Resources
Powerpoint Slides on Cyclobenzaprine
Images of Cyclobenzaprine
Podcasts & MP3s on Cyclobenzaprine
Videos on Cyclobenzaprine
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Cyclobenzaprine
Discussion Groups on Cyclobenzaprine
Patient Handouts on Cyclobenzaprine
Blogs on Cyclobenzaprine
Cyclobenzaprine in the News
Cyclobenzaprine in the Marketplace
Return to top
International Resources
Cyclobenzaprine en Español
Return to top
Adapted from the FDA Package Insert.